FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, specifically to ophthalmology, and is intended to treat dry eye syndrome in a human or other mammal suffering from same. Ophthalmic composition contains an oil mixture containing castor oil and linseed oil; sodium carboxymethyl cellulose; polysorbate 80; one or more components for improving tonicity, selected from a group consisting of glycerine, erythritol and carnitine; Pemulen TR-2. Mixture of castor oil and linseed oil is emulsified in aqueous phase. In another embodiment, ophthalmic composition contains an oil mixture consisting of castor oil and linseed oil; sodium carboxymethyl cellulose; glycerine; polysorbate 80; Pemulen TR-2; carnitine; erythritol; boric acid; water. Mixture of castor oil and linseed oil is also emulsified in aqueous phase.
EFFECT: using group of inventions increases efficiency of treating dry eye syndrome, eliminates manifestation of discomfort when using composition, which is achieved by improving distribution and reduction of viscosity of composition.
8 cl, 5 tbl, 2 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
DRY EYE TREATMENT COMPOSITIONS | 2012 |
|
RU2651046C2 |
STABILIZED OPHTHALMIC COMPOSITIONS CONTAINING OMEGA-3-ACIDS | 2015 |
|
RU2697844C2 |
METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
PHARMACEUTICAL FORMULATIONS OF NON-POLAR AND POLAR LIPIDS FOR OPHTHALMOLOGICAL APPLICATION | 2007 |
|
RU2495661C2 |
COMPOSITION FOR EFFECTIVE LIPID DELIVERY TO HUMAN TEAR FILM USING SALT-SENSITIVE EMULSION SYSTEM | 2012 |
|
RU2772357C2 |
OPHTHALMIC COMPOSITION CONTAINING CYCLOSPORINE AND TREHALOSE | 2015 |
|
RU2700927C2 |
OPHTHALMOLOGICAL COMPOSITIONS | 2017 |
|
RU2756758C2 |
AQUEOUS OPHTHALMIC SOLUTION BASED ON CYCLOSPORIN A | 2013 |
|
RU2634267C2 |
LIPID-BASED OPHTHALMIC EMULSION | 2019 |
|
RU2793333C2 |
ANDROGEN COMPOSITION FOR TREATING OPHTHALMIC CONDITIONS | 2012 |
|
RU2599036C2 |
Authors
Dates
2016-07-10—Published
2010-06-03—Filed